ANGPTL3 and cardiovascular disorder: Inhibition of ANGPTL3 activity leads to an important reduction in all major lipoprotein types, and loss-of-function (LOF) variants of ANGPTL3 were associated with a protective role against cardiovascular disorders, decreasing the risk of coronary heart disease by 34% [92].